البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
CHLORAMPHENICOL
TEVA ISRAEL LTD
D10AF03
OINTMENT
CHLORAMPHENICOL 3 %
DERMAL
Required
TEVA ISRAEL LTD, ISRAEL
CHLORAMPHENICOL
CHLORAMPHENICOL
Antibiotic.
2021-12-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor’s prescription only Synthomycine 3% Skin ointment Composition Chloramphenicol 3% For information regarding inactive ingredients and allergens, see section 2 “Important information about some of the ingredients of the medicine” and section 6 – “Additional information”. Read the entire leaflet carefully before using the medicine. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for your treatment. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? For treating superficial skin infections caused by microorganisms sensitive to chloramphenicol. Therapeutic class Topical antibacterial. 2. BEFORE USING THE MEDICINE Do not use this medicine if: • You are sensitive (allergic) to chloramphenicol or to any of the other ingredients this medicine contains (see below in the section “Important information about some of the ingredients of the medicine” and section 6 “Additional information”). • You or any of your family members have a history of anemia, bleeding or other problems in the blood system or bone marrow. These problems may include a severe drop in the amount of red blood cells or lower than normal blood count. Special warnings regarding the use of the medicine This preparation contains chloramphenicol, which may cause changes in the blood profile upon prolonged use. Therefore, prolonged use of the preparation should be avoided. The preparation is not intended for use in the eyes, do not allow the preparation to come into contact with them. In case of contact with the eyes, wash them immediately with water. Drug interactions If you are taking, or have recently taken, other medicines, including non-prescription medicines and nutritional supplements, tell اقرأ الوثيقة كاملة
Synthomycine 3% FW Notification 12/2023 Summary of Product Characteristics Synthomycine 3% Dermal Ointment 1. NAME OF THE MEDICINAL PRODUCT Synthomycine 3% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Composition Active Ingredient Chloramphenicol 3% For the full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM Ointment. Yellow ointment. 4.4 Special warnings and precautions for use 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Antibiotic. Chloramphenicol is effective against certain protozoa, rickettsia and virus-like infections, as well as against many Gram-positive and Gram-negative bacteria. It is useful in the treatment of superficial pyodermas, impetigo, acute folliculitis, seborrhea- like streptodermatitis, and infectious eczematoid dermatitis. 4.2 Posology and method of administration Direction for use Patients should be cautioned to report to their physician if no improvement in their condition occurs after 4-5 days of treatment. Apply to the infected area 3-4 times daily after cleansing. 4.3 Contraindications Known hypersensitivity to any of the active ingredients or to any of the excipients listed in section 6.1. Patients who have experienced myelosuppression during previous exposure to chloramphenicol. Synthomycine 3% FW Notification 12/2023 Patients with a known personal or family history of blood dyscrasias including aplastic anaemia. 4.4 Special warnings and precautions for use This medicine is not intended for ophthalmic application. Chloramphenicol toxicity has been reported following chronic exposure. Discontinue promptly if sensitization or irritation occurs. The use of chloramphenicol may occasionally result in overgrowth of non- susceptible organisms, including fungi. If any new infection appears during treatment, the antibiotic should be discontinued and appropriate measures taken. In severe infections the topical use of chloramphenicol should be supplemented by appropriate systemic treatment. Prolonged or frequent intermittent use of topical chloramphenicol should be avoided, b اقرأ الوثيقة كاملة